Article Text

other Versions

PDF

Quadriceps strength predicts mortality in patients with moderate to severe Chronic Obstructive Pulmonary Disease
  1. Elisabeth Bryony Swallow (e.swallow{at}ic.ac.uk)
  1. Royal Brompton Hospital, United Kingdom
    1. Diana Reyes
    1. Royal Brompton Hospital, United Kingdom
      1. Nicholas S Hopkinson (n.hopkinson{at}ic.ac.uk)
      1. Royal Brompton Hospital, United Kingdom
        1. William Ding-Cheong Man (william.man{at}kcl.ac.uk)
        1. King's College Hospital, United Kingdom
          1. Raphael Porcher
          1. Hospital Saint-Louis, Paris, France
            1. Edward J Cetti
            1. Royal Brompton hospital, United Kingdom
              1. Alastair J Moore (a.moore{at}ic.ac.uk)
              1. Royal Brompton Hospital and NHLI, United Kingdom
                1. John Moxham (john.moxham{at}kingsch.nhs.uk)
                1. Kings College, United Kingdom
                  1. Michael I Polkey (m.polkey{at}rbh.nthames.nhs.uk)
                  1. Royal Brompton Hospital, United Kingdom

                    Abstract

                    Background: Prognosis in chronic obstructive pulmonary disease (COPD) is poorly predicted by indices of airflow obstruction, because other factors which reflect the systemic nature of the disease also influence prognosis. This study was undertaken to test the hypothesis that a reduction in quadriceps maximal voluntary contraction force (QMVC), is a useful predictor of mortality in patients with COPD.

                    Methods: A mortality questionnaire was sent to the primary care physician of 184 COPD patients who had undergone quadriceps strength measurement over the last five years. QMVC was expressed as a % of the patients' body mass index. The endpoint measured was death or lung transplantation and median (range) follow up was 38 (1-54) months.

                    Results: Data was obtained for 162 patients (108 male, 54 female) with a mean FEV1 % predicted of 35.6 (16.2) giving a response rate of 88%. Transplant free survival of the cohort was 93.5% at 1 year and 87.1% at 2 years. Cox regression models showed that the mortality risk increased with increasing age and with reducing QMVC. Only age, Hazard ratio 1.72 (95% CI 1.14- 2.60), p=0.01 and QMVC, HR 0.91 (0.83-0.99), p=0.036 continued to be statistically significant predictors of mortality when controlled for other variables in the multivariate analysis.

                    Conclusion: Quadriceps MVC is simple and provides more powerful prognostic information in COPD than that provided by age, Body Mass Index and FEV1.

                    • COPD
                    • mortality
                    • quadriceps weakness

                    Statistics from Altmetric.com

                    Request permissions

                    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                    Linked Articles